The principal effect of our derivative instruments designated in cash flow hedging relationships on our results of operations, as well as OCI, net of income tax effect, is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivative Instruments in Designated Cash Flow Hedging Relationships |
|
Net Gain (Loss) Recognized in OCI |
|
Location of Net Gain (Loss) Reclassified from AOCI to Income (Loss) |
|
Net Gain (Loss) Reclassified from AOCI to Income (Loss) |
(in millions) |
|
|
|
|
|
|
For the Six Months Ended August 31, 2023 |
|
|
|
|
|
|
Foreign currency contracts |
|
$ |
149.9 |
|
|
Sales |
|
$ |
(0.2) |
|
|
|
|
|
Cost of product sold |
|
65.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pre-issuance hedge contracts |
|
0.6 |
|
|
Interest expense |
|
(0.3) |
|
|
|
$ |
150.5 |
|
|
|
|
$ |
65.2 |
|
|
|
|
|
|
|
|
For the Six Months Ended August 31, 2022 |
|
|
|
|
|
|
Foreign currency contracts |
|
$ |
71.3 |
|
|
Sales |
|
$ |
(1.2) |
|
|
|
|
|
Cost of product sold |
|
21.9 |
|
|
|
|
|
|
|
|
Pre-issuance hedge contracts |
|
15.7 |
|
|
Interest expense |
|
(0.6) |
|
|
|
$ |
87.0 |
|
|
|
|
$ |
20.1 |
|
|
|
|
|
|
|
|
For the Three Months Ended August 31, 2023 |
|
|
|
|
|
|
Foreign currency contracts |
|
$ |
70.6 |
|
|
Sales |
|
$ |
(0.2) |
|
|
|
|
|
Cost of product sold |
|
39.3 |
|
|
|
|
|
|
|
|
Pre-issuance hedge contracts |
|
— |
|
|
Interest expense |
|
(0.1) |
|
|
|
$ |
70.6 |
|
|
|
|
$ |
39.0 |
|
|
|
|
|
|
|
|
For the Three Months Ended August 31, 2022 |
|
|
|
|
|
|
Foreign currency contracts |
|
$ |
(8.2) |
|
|
Sales |
|
$ |
(0.6) |
|
|
|
|
|
Cost of product sold |
|
10.8 |
|
|
|
|
|
|
|
|
Pre-issuance hedge contracts |
|
— |
|
|
Interest expense |
|
(0.1) |
|
|
|
$ |
(8.2) |
|
|
|
|
$ |
10.1 |
|
The effect of our undesignated derivative instruments on our results of operations is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivative Instruments Not Designated as Hedging Instruments |
|
|
|
Location of Net Gain (Loss) Recognized in Income (Loss) |
|
Net Gain (Loss) Recognized in Income (Loss) |
(in millions) |
|
|
|
|
|
|
For the Six Months Ended August 31, 2023 |
|
|
|
|
|
|
Commodity derivative contracts |
|
|
|
Cost of product sold |
|
$ |
(15.6) |
|
Foreign currency contracts |
|
|
|
Selling, general, and administrative expenses |
|
22.5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
6.9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivative Instruments Not Designated as Hedging Instruments |
|
|
|
Location of Net Gain (Loss) Recognized in Income (Loss) |
|
Net Gain (Loss) Recognized in Income (Loss) |
(in millions) |
|
|
|
|
|
|
For the Six Months Ended August 31, 2022 |
|
|
|
|
|
|
Commodity derivative contracts |
|
|
|
Cost of product sold |
|
$ |
33.1 |
|
Foreign currency contracts |
|
|
|
Selling, general, and administrative expenses |
|
(2.6) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
30.5 |
|
|
|
|
|
|
|
|
For the Three Months Ended August 31, 2023 |
|
|
|
|
|
|
Commodity derivative contracts |
|
|
|
Cost of product sold |
|
$ |
19.1 |
|
Foreign currency contracts |
|
|
|
Selling, general, and administrative expenses |
|
9.8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
28.9 |
|
|
|
|
|
|
|
|
For the Three Months Ended August 31, 2022 |
|
|
|
|
|
|
Commodity derivative contracts |
|
|
|
Cost of product sold |
|
$ |
(15.4) |
|
Foreign currency contracts |
|
|
|
Selling, general, and administrative expenses |
|
(8.8) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
(24.2) |
|
|